(Q37925136)

25 August 2017

Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients (English)

1 reference

Adaptive radiation therapy

25 August 2017

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

Zulfiquer Otty

1

1 reference

25 August 2017

Monika Buhrer Skinner

2

1 reference

25 August 2017

Joshua Dass

3

1 reference

25 August 2017

Michael Collins

4

1 reference

25 August 2017

Jennifer Mooi

5

1 reference

25 August 2017

Kandeepan Thuraisingam

6

1 reference

25 August 2017

Sabe Sabesan

7

1 reference

25 August 2017

language of work or name

1 reference

1 September 2011

1 reference

Asia Pacific Journal of Clinical Oncology

25 August 2017

1 reference

25 August 2017

7

1 reference

25 August 2017

3

1 reference

25 August 2017

287-292

1 reference

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2011.01405.X

10.1111/J.1743-7563.2011.01405.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference